Market Cap: $58.86B
Market Cap: $58.86B

Becton, Dickinson and Company ( BDX ) has recently showcased its commitment to innovation and growth in the medical technology sector through a series of strategic initiatives and partnerships. As the…

Becton Dickinson & Company (Ticker: BDX) announces an important milestone with the award of an Innovative Technology contract for its BD CentroVena One Insertion System from Vizient. This contract hig…

Becton Dickinson & Company (Ticker: BDX) has recently received significant recognition in the healthcare industry with its BD CentroVena One Insertion System being awarded an Innovative Technology con…

Becton Dickinson & Company (Ticker: BDX) continues to strengthen its position in the medical technology arena, having recently received an Innovative Technology contract from Vizient for its BD® Centr…

Becton Dickinson & Company (Ticker: BDX) faces significant challenges as it recently initiated multiple voluntary Class I sub-recalls of its BD Spinal Tray products in the United States. These recalls…

Becton, Dickinson and Company (Ticker: BDX) capitalizes on innovation in urologic care with the launch of its new Elyra™ Thulium Fiber Laser (TFL) System. This cutting-edge technology is specifically…
Becton Dickinson & Company (Ticker: BDX) announces a significant shift in its executive leadership, appointing Vitor Roque as the new executive vice president and chief financial officer. This transit…
Becton Dickinson & Company (Ticker: BDX) has announced a significant partnership with Wellstar Health System aimed at enhancing medication management through the deployment of AI-powered technologies.…

Becton Dickinson & Company (BD) has launched its innovative BD® CentroVena One™ Insertion System, marking a significant advancement in the medical technology sector aimed at enhancing patient safety a…
BD Enters European Market with Innovative Medication Solutions Becton, Dickinson and Company (BD) reinforces its commitment to enhancing healthcare technology with the recent announcement of its expan…
BD Expands into European Healthcare with Advanced Medication Solutions Becton, Dickinson and Company (BD) marks a significant development in the healthcare sector by introducing its innovative medicat…
BD Advances Vascular Treatment with CE Mark for Revello™ Stent Becton, Dickinson and Company (BD) recently announces that its Revello™ Vascular Covered Stent has received CE Marking, marking a signifi…
BD Introduces the Revello™ Vascular Covered Stent: A Breakthrough for Peripheral Artery Disease Treatment Becton, Dickinson and Company (BD) announces the CE marking of its innovative Revello™ Vascula…
BD Enhances Debt Management Through Strategic Tender Offers Becton, Dickinson and Company (BD), a leading player in the global medical technology sector, recently reports on the results of its early t…
BD Enhances Debt Management Strategy with Tender Offer Expansion Becton, Dickinson and Company (BD), a leading global player in medical technology headquartered in Franklin Lakes, New Jersey, is takin…
Becton Dickinson Revamps Debt Management Strategy through Tender Offers Becton, Dickinson and Company (BD), a key player in the global medical technology industry, has recently announced significant m…
BD reshapes long-term debt with $1.6 billion multi-series tender offer Becton, Dickinson and Company is launching a coordinated cash tender offer program that targets multiple series of its outstandin…
BD completes spin-off with Waters, pivots to pure‑play medtech strategy Franklin Lakes, N.J. — Becton, Dickinson and Company completes the previously announced spin‑off of its Biosciences & Diagnostic…
BD completes Waters combination, pivots to a focused MedTech company Becton Dickinson & Company completes the previously announced spin-off of its Biosciences & Diagnostic Solutions businesses and com…
Data storm lands on medtech procurement Next week’s delayed US jobs and inflation reports are forcing hospitals and medical suppliers such as Becton Dickinson & Company to reassess near-term purchasin…
Economic data delay puts health equipment demand in focus U.S. jobs and inflation reports, delayed briefly by the government and now scheduled for release together next week, put the Federal Reserve’s…
BD Launches AI-Driven Research Cloud 7.0 to Transform Scientific Collaboration Becton, Dickinson and Company (BD) announces the global commercial release of BD® Research Cloud 7.0, a significant advan…
BD Unveils Advanced AI Tool to Enhance Research Efficiency Becton, Dickinson and Company (BD) announces the global commercial launch of BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, a…
BD Hosts Virtual Annual Meeting to Engage Shareholders in Future Vision Becton, Dickinson and Company (BD), a leading global medical technology firm, sets the date for its virtual 2026 Annual Meeting…
BD Prepares for Virtual Shareholder Engagement in 2026 Becton, Dickinson and Company (BD), a leader in the global medical technology sector, announces its virtual 2026 Annual Meeting of Shareholders s…
Legal Challenges for Becton Dickinson Highlight Monopolistic Concerns in Medical Devices Becton, Dickinson & Company (BDX) finds itself confronting a serious legal challenge that questions its busines…
Becton Dickinson Faces Legal Scrutiny Over Alleged Monopolistic Practices in Hernia Mesh Market Becton, Dickinson & Company (BDX) finds itself at the center of a legal storm, as it faces allegations o…
Becton Dickinson Faces Legal Scrutiny Over Allegations of Monopolistic Practices in Hernia Mesh Market Becton, Dickinson & Company (BDX) is currently confronting significant legal challenges related t…
BD Partners with University of Pennsylvania to Advance Immune Profiling Research Becton, Dickinson and Company (BD) has embarked on a strategic collaboration with the Institute for Immunology and Immu…
BD Partners with University of Pennsylvania to Advance Immune Profiling Research Becton, Dickinson and Company (BD) announces a strategic collaboration with the Institute for Immunology and Immune Hea…
BD Launches New Configurations of FACSDiscover™ A8 Cell Analyzers to Enhance Research Capabilities Becton, Dickinson and Company (BD) announces the global commercial release of new configurations for…
BD Launches New Configurations for FACSDiscover™ A8 Cell Analyzers, Revolutionizing Cellular Research Becton, Dickinson and Company (BD) announces the global launch of new configurations for its BD FA…
BD Launches New Configurations of FACSDiscover™ A8 Cell Analyzers to Empower Scientific Research Becton, Dickinson and Company (BD) announces the global commercial release of new configurations for it…
Shifting Investor Sentiment: A Positive Outlook for Becton Dickinson & Company Becton Dickinson & Company, a leader in medical technology, experiences a notable decrease in short interest as a percent…
BD Strengthens Board with New Appointments to Navigate Healthcare Innovation Becton, Dickinson and Company (BD), a leading global medical technology enterprise, announces the strategic appointment of…
BD Strengthens Leadership with New Board Appointments to Enhance Patient Care Becton, Dickinson and Company (BD), a leader in medical technology, announces the addition of Robert "Robbie" Huffines and…
Becton Dickinson's Commitment to Innovation and Shareholder Value Becton, Dickinson and Company (BD) recently demonstrates its solid financial health and commitment to shareholder value through a seri…
Becton Dickinson's Commitment to Innovation and Shareholder Value Becton Dickinson and Company (BD) demonstrates a robust commitment to both innovation and shareholder returns, as evidenced by its rec…
BD Expands Access to Cervical Cancer Screening with Innovative Self-Collection HPV Testing Solution Becton, Dickinson and Company (BD), a leading player in the global medical technology sector, has la…
### Transforming Healthcare Connectivity: BD Incada™ Connected Care Platform Launch Becton, Dickinson and Company (BD) unveils the BD Incada™ Connected Care Platform, marking a pivotal advancement in…
BD's Revolutionary Incada™ Connected Care Platform Transforms Healthcare Delivery Becton, Dickinson and Company (BD) has launched the BD Incada™ Connected Care Platform, a groundbreaking, AI-driven, c…
BD Celebrates Milestone in Manufacturing Excellence Becton, Dickinson and Company (BD) marks a significant milestone at its Broken Bow, Nebraska facility, celebrating 65 years of manufacturing excelle…
Becton Dickinson Faces Leadership Transition Amid Market Fluctuations Becton Dickinson & Company (BD) is currently undergoing a notable leadership shift as it announces the departure of Chief Financia…
Becton Dickinson Faces Leadership Transition Amid Financial Updates Becton Dickinson & Company, a global leader in medical technology, is currently navigating a significant leadership change with the…
Becton Dickinson Faces Leadership Transition Amid Market Volatility Becton Dickinson & Company (BD) navigates a challenging environment following the announcement of a significant leadership change. T…
BD Expands Its Horizons Through Innovative Partnership with Opentrons Labworks Becton, Dickinson and Company (BD), a leader in medical technology, forges a multi-year collaboration with Opentrons Labw…
BD and Opentrons Collaborate to Revolutionize Single-Cell Multiomics Automation Becton, Dickinson and Company (BD), a leader in medical technology, forges a strategic partnership with Opentrons Labwor…
BD Partners with Opentrons to Enhance Single-Cell Multiomics Research Becton, Dickinson and Company (BD), a leading name in global medical technology, announces a significant partnership with Opentron…
Becton Dickinson Navigates Complex Healthcare Landscape Amidst Analyst Opinions Becton Dickinson & Company (BDX) faces a multifaceted healthcare environment where analysts express contrasting views on…
Becton Dickinson's Strategic Position in a Dynamic Market Environment Becton Dickinson & Company (BD), a leading medical technology firm, finds itself navigating a complex and rapidly evolving healthc…